Physician profile
Laura Young
NPI 1689349243
$5,097.96
in general payments reported to CMS, 2019-2025
10 companies · $4,333 in 2025
The $4,333 reported for 2025 was more than what 98% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $24.55 · 2023: $187 · 2024: $553 · 2025: $4,333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,600 · Food and Beverage: $1,323 · Honoraria: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,600.00 |
| Food and Beverage | $1,323.41 |
| Honoraria | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,403.08 | 2024-2025 | |
| Alkermes, INC. | $166.34 | 2023-2024 | Lybalvi, Aristada |
| H2-Pharma, LLC | $150.00 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $134.43 | 2022-2023 | |
| Otsuka America Pharmaceutical, INC. | $99.75 | 2024 | Rexulti |
| Janssen Pharmaceuticals, INC | $76.55 | 2023-2025 | Spravato |
| Neurocrine Biosciences, INC. | $19.32 | 2025 | |
| Hologic Sales and Service, LLC | $18.38 | 2024 | Acessa Provu System, Novasure |
| Lundbeck LLC | $17.88 | 2024 | Rexulti |
| Supernus Pharmaceuticals, INC. | $12.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.